NETRF promotes collaboration and resource sharing among funded researchers and the community, both crucial in advancing science.
Unique research resources created by NETRF funds must be readily available to qualified individuals, after publication. NETRF has partnered with several like-minded organizations that promote resource sharing.
In partnership with Rare Cancer Research Foundation (RCRF) and pattern.org, tissues from NET patients that are undergoing surgery are directed to the Cancer Cell Line Factory (CCLF) at the Broad Institute, for generation of NET cell lines.
The NETRF researcher community
NETRF’s Annual Research Symposium (link to Research Symposium Page) is a safe platform to present information on unpublished research resources. It has spearheaded multiple collaborative projects between investigators that are now leading to much needed translational research with therapeutic potential.
Grant programs via partners
NETRF is dedicated to accelerating progress for better treatments and potential cures through partnerships with aligned organizations and private foundations.
Sponsored annual grants:
The latest in NET News
Immunotherapy has been called one of the most significant advances in cancer in decades. While
Antibody-drug conjugate aims to combine the benefits of targeted therapy and chemotherapy Renata Jaskula-Sztul, PhD,
https://www.youtube.com/watch?v=k1906SABias The Neuroendocrine Tumor Research Foundation (NETRF) has invested more than $1.5 million in advancing